About Us
Esmero Research pvt. ltd.
Companies are investing in research and development of personalized treatments and marketing them to patients and healthcare providers
The Global Pharma Industry is embracing new marketing strategies and innovations with a focus on Digital Marketing, Personalized Medicine, Patient-Centric Marketing, Collaborations & Partnerships and Online Pharmacy Platforms. These innovations are helping to drive growth and create new opportunities for the industry.
In this landscape, ERPL is poised to fill the gap of global pharma importers in terms of large product basket from general to highly specialised niche therapy products accompanied with regulatory & marketing capabilities, efficient integration of complete supply chain. The most captivating is our profound sense of innovative & flexible trade arrangement with all stake holders whether B2B or P2P.
Manufacturing Facilities (Semi-Regulated)
SRA Approved Facilities (In-licensed portfolio)
Products
Global Presence
Years of Expertise
Mission
Vision
Values
In everything we do, ESMERO values integrity, partnership, excellence, collaboration, customer focus, responsibility, and adaptability.
- Integrity: We uphold honesty and strong moral principles in all our actions.
- Excellence: We strive for the highest standards in everything we do.
- Partnership: We believe in building lasting relationships based on trust and collaboration.
- Adaptability: We evolve with the ever-changing pharmaceutical landscape.
- Responsibility: We are accountable for delivering quality healthcare solutions globally.
Our journey
Global Presence:
- Over 35 registered pharma formulation brands worldwide and counting (P2P)
- 30 Global Partners in 22 countries like South Africa, Vietnam, Colombia, Italy& others
- 10 customized brands under contract manufacturing for various countries (B2B)
- 250 + Products’ Ready COPPs
- 21 specialty cosmetic brands under registration in Vietnam, in-licensed from Italy
- 100+ dossiers ready for filling for 2025
- Achieved 100% Y-O-Y growth
Operations in Nigeria Subsidiary:
- Registered office in Lagos, the capital of Nigeria
- Well-equipped warehouse and depots in three states for efficient supply chain management Distributing Esmero’s 9 registered products
- Engaging with buyers across Nigeria with a dedicated team of 13, including 3 expatriates
- We have a strong presence in Nigeria, through our subsidiary, with 9 registrations and a dedicated team managing operations in key markets.
Global Growth Plans:
- Building on our success in Nigeria, we are excited to announce upcoming subsidiaries in Colombia, South Africa, Vietnam, and the Philippines
- These strategic locations will enable us to better serve communities worldwide, ensuring access to essential medications and fostering healthier futures
Capabilities and Services:
- We specialize in manufacturing and exporting a wide range of pharmaceutical products, including tablets, capsules, injectables, and topical treatments. With a commitment to regulatory compliance and quality assurance.
- We offer comprehensive services such as contract manufacturing, regulatory dossier preparation, and market-specific product licensing. Our in-house labs ensure that all our products meet international standards, including WHO-GMP, cGMP, and ISO certifications.
- Esmero boasts Good Manufacturing Facilities approved by various authorities in Africa, South-East Asia, LATAM, CIS Countries and the EU
- Our specialty product portfolio is in-licensed from EU and USFDA-approved facilities